title: Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint.
authors.affiliation: Université Clermont Auvergne, Inserm, U1107, NEURO-DOL, CHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Kerckhove
authors.affiliation: CHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Pereira
authors.affiliation: Université Clermont Auvergne, Inserm, U1071, USC INRA 2018, M2iSH, CHU Clermont-Ferrand, service de chirurgie et oncologie digestive, Clermont-Ferrand, France.
authors.forename: Denis
authors.initials: D
authors.lastname: Pezet
authors.affiliation: Université Clermont Auvergne, Inserm, U1107, NEURO-DOL, CHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France.
authors.forename: David
authors.initials: D
authors.lastname: Balayssac
mesh_terms: D000970:Antineoplastic Agents; D006801:Humans; D010146:Pain; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents